To the Editor, Almost 10%–30% of coronavirus disease 2019 (COVID-19) survivors experience several lingering pulmonary complications, including dyspnea, chronic cough, and pulmonary fibrosis after initial recovery, known as long COVID or postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC).1 The pathogenesis of PASC is complex and multifactorial, and underlying mechanisms, specifically, the characterization of immune dysregulation, and whether the...